Executives from Australian companies express significant optimism and eagerly anticipate the upcoming seventh China International Import Expo (CIIE), scheduled to take place in Shanghai in November 2024. Emphasizing the CIIE's prominence on the global trade calendar, James Hudson, a representative from an Australian genomic life science company, conveyed his enthusiastic anticipation for participating in this influential event. The sentiments highlight the considerable importance Australian firms attribute to the CIIE, showcasing their eagerness to engage in international trade opportunities and collaborations.
During a promotional event in Sydney for the upcoming seventh CIIE, Hudson, the Corporate Affairs Director of EZZ Life Science Holdings Ltd, expressed the event's immense significance. He highlighted its role as a crucial platform for businesses like EZZ to establish connections with new buyers, educate consumers about their products, and foster high-level relationships. The event, which saw the active participation of nearly 200 representatives from government organizations, business associations from both China and Australia, and local enterprises, emphasized the pivotal role of the CIIE in promoting trade and business relations between the two nations.
Participants emphasized that the CIIE serves as a vital window for enhancing China-Australia trade and business ties, presenting a valuable opportunity for local companies to better understand and seize prospects in the Chinese market. Ning Feng, President of the National Exhibition and Convention Center (Shanghai), reported that preparations for the seventh CIIE are progressing rapidly, with the contracted exhibition area surpassing 180,000 square meters. He expressed the Center's willingness to support more Australian companies in entering the Chinese market, fostering success and achievements for them.